Loss-of-function experiments revealed that FEZF1-AS1 knockdown decreased the protein levels of ATG5 and LC3, suggesting that the inhibition of FEZF1-AS1 knockdown on autophagy of GC cells. The gene discussed is FEZF1; the disease is gastric cancer.